DelistingSep 2, 2026, 04:27 PM
IRIDEX CORP Receives Nasdaq Delisting Warning for Low Stock Price
AI Summary
IRIDEX CORP (IRIX) received a notification from Nasdaq indicating its common stock has fallen below the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company has 180 days, until February 23, 2027, to regain compliance. During this period, the stock will continue to trade on Nasdaq without immediate impact. IRIDEX is exploring options to meet the requirement, with potential for an additional 180-day extension if specific conditions are met, including a reverse stock split. Failure to comply could lead to delisting.
Key Highlights
- IRIDEX CORP received a non-compliance notice from Nasdaq for failing to meet the $1.00 minimum bid price requirement.
- The company has until February 23, 2027, to regain compliance by achieving a closing bid price of at least $1.00 for ten consecutive business days.
- Failure to comply within the cure period may result in an additional 180 days if certain conditions are met, including a reverse stock split.
- The notice has no immediate impact on the listing or business operations; trading continues on Nasdaq during the cure period.
- IRIDEX CORP is actively monitoring its stock price and considering options to regain compliance.
Price Impact
More from IRIX